| Q34662884 | Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia |
| Q34342808 | Allogeneic and autologous transplantation for chronic lymphocytic leukemia |
| Q41986069 | Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over? |
| Q34803868 | B-chronic lymphocytic leukemia: practical aspects |
| Q46925369 | Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. |
| Q47387344 | Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells |
| Q33873273 | Management of chronic lymphocytic leukaemia |
| Q54278466 | Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part I. Chronic Lymphocytic Leukemias. |
| Q58041763 | Novel flow-cytometric analysis based on BCD5+ subpopulations for the evaluation of minimal residual disease in chronic lymphocytic leukaemia |
| Q41682806 | Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study |
| Q36284521 | Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia |
| Q36003096 | Stem cell transplantation for chronic lymphocytic leukaemia |
| Q36952609 | Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence? |
| Q62735936 | The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis |
| Q36346370 | Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies |